Private Equity wire announces Calculus Capital’s latest hire, Alexander Crawford, Investment Director.Private equity firm Calculus Capital, a specialist in Enterprise Investment Scheme (EIS) funds, has appointed Alexander Crawford as Investment Director. Alexander has over 20 years’ corporate finance experience, including ten years with Robert Fleming & Co, Evercore Partners and JP Morgan in London, New … Continued
Month: June 2015
Award winning private equity fund manager Calculus Capital strengthens investment team with senior hire Calculus Capital, the private equity firm and pioneer of Enterprise Investment Scheme (‘EIS’) funds, is pleased to announce the appointment of Alexander Crawford as Investment Director. Alexander has over 20 years’ corporate finance experience, including ten years with Robert Fleming & … Continued
We are delighted to share that Epistem has been awarded ‘Best for Innovation’ at the North West BVCA Management Team Awards. All regional winners are now automatically entered into the national contest, the results of which will be announced at a ceremony in London on 25th June. Good Luck to the Epistem team!
Immunotherapy treatments that use the immune system to fight cancer, have hit the headlines this week – the BBC ran an article ‘Have we cured cancer?” in addition to articles in news outlets such as the Guardian “Immunotherapy: the big new hope for cancer treatment“. Scancell, a portfolio company of Calculus Capital, develops novel immunotherapies for the … Continued